MedTrace Logo

Phase Angle and Chronic Intestinal Inflammatory Diseases

NCT05106738 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2023-12-05

No results posted yet for this study

Summary

Phase angle (PhA) is a biometric parameter measured by bioimpedance analysis (BIA), which reflects organism cellularity and tissues hydration. In addition, since it correlates with the presence of inflammation and the nutritional status, it could be useful to monitor inflammatory bowel disease (IBD) activity. The aim of this study was to establish the potential use of PhA as a new non-invasive and sensitive marker correlated with mucosal healing and/or IBD activity.

Conditions

  • Inflammatory Bowel Diseases
  • Mucosal Inflammation
  • Leukocyte L1 Antigen Complex
  • C-Reactive Protein

Sponsors & Collaborators

  • University of Bari

    lead OTHER

Principal Investigators

  • Michele Barone, MD · University of Bari

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-06-01
Primary Completion
2023-10-31
Completion
2023-11-30

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05106738 on ClinicalTrials.gov